Publication:
Evaluation of coronavirus disease 2019-positive patients with febrile convulsions

dc.contributor.authorToker, Rabia Tütüncu
dc.contributor.authorDemir, Aylin Bican
dc.contributor.buuauthorBİCAN DEMİR, AYLİN
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı
dc.contributor.orcid0000-0001-6739-8605
dc.contributor.researcheridKHB-9765-2024
dc.date.accessioned2024-09-13T06:47:53Z
dc.date.available2024-09-13T06:47:53Z
dc.date.issued2022-12-01
dc.description.abstractObjective: Febrile convulsion is a common seizure type in children between 6 months and 6 years of age and is seen in 2%-5% of children.1 Coronavirus disease 2019 spread rapidly and became a pandemic. As coronavirus disease 2019 can be seen in epilepsy patients, the relationship between coronavirus disease 2019 and seizures is not clear yet.2 This study aimed to evaluate the characteristics of coronavirus disease 2019-positive patients with febrile convulsions and compare them with coronavirus disease 2019-negative patients with febrile convulsions regarding their clinical features.Methods: Forty patients were included in the study. In our country, diagnosing, monitoring, and treating coronavirus disease 2019 are performed according to the Turkish Ministry of Health coronavirus disease 2019 Scientific Committee guidelines.Results: Twelve of the patients were coronavirus disease 2019 positive, whereas 28 were coronavirus disease 2019 negative. While the rate of complex febrile convulsion was 50% in the coronavirus disease 2019-positive group, this ratio was 25% in the coronavirus disease 2019-negative patient group.Conclusions: Seizures occur in the presence of higher-grade fever in coronavirus disease 2019-positive cases. On the other hand, the probability of seizures to occur focally and recur during the same disease period might be higher. Male gender and maternal history of febrile convulsions may be the risk factors.
dc.identifier.doi10.5152/ArchEpilepsy.2022.222956
dc.identifier.eissn2792-0550
dc.identifier.endpage162
dc.identifier.issue4
dc.identifier.startpage159
dc.identifier.urihttps://doi.org/10.5152/ArchEpilepsy.2022.222956
dc.identifier.urihttps://archepilepsy.org/articles/doi/ArchEpilepsy.2022.222956
dc.identifier.urihttps://hdl.handle.net/11452/44700
dc.identifier.volume28
dc.identifier.wos000908847100004
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherAves
dc.relation.journalEpilepsi Arşivler
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRisk-factors
dc.subjectSeizures
dc.subjectFebrile convulsion
dc.subjectChildhood
dc.subjectCovid-19
dc.subjectInfections
dc.subjectPrognosis
dc.subjectSimple seizure
dc.subjectComplex seizure
dc.subjectTreatment
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectClinical neurology
dc.subjectNeurosciences & neurology
dc.titleEvaluation of coronavirus disease 2019-positive patients with febrile convulsions
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication8b72317c-2cda-4511-bba9-51f797dadec4
relation.isAuthorOfPublication.latestForDiscovery8b72317c-2cda-4511-bba9-51f797dadec4

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Demir_Toker_2022.pdf
Size:
751.08 KB
Format:
Adobe Portable Document Format

Collections